GAXOS.AI INC. Annual Report - Fiscal Year 2025 Review

Dive into GAXOS.AI INC.'s 2025 journey. This report offers investors a clear, concise look at the company's operations, financial health, and future plans, drawing directly from its SEC 10-K filing for the fiscal year ended December 31, 2025.

1. Business Overview

GAXOS.AI INC. (NASDAQ: GXAI) is a technology company that develops and deploys artificial intelligence (AI) solutions across various sectors. These include defense, health and wellness, entertainment (especially gaming), and general productivity. The company's mission is to create impactful AI-powered tools that solve real-world problems.

As of March 25, 2026, GAXOS.AI had approximately 10.2 million shares outstanding. The market value of its publicly traded shares (public float) was about $9.7 million as of June 30, 2025. The company operates as both a "smaller reporting company" and an "emerging growth company." This status allows GAXOS.AI to benefit from reduced public reporting requirements, meaning it may provide less detailed financial and operational information than larger, more established firms. Companies typically qualify for this status if they have less than $1.235 billion in public float or less than $100 million in annual revenues, which permits them to defer certain compliance obligations.

Operational Highlights & Product Development (2025): GAXOS.AI significantly expanded its product development throughout 2025, focusing on diverse AI applications:

• Gaxos Labs (Innovation Hub): Launched in September 2024, Gaxos Labs serves as the company's central hub for developing and deploying new AI applications.
  • AI for Game Developers (September 2024): GAXOS.AI introduced a generative AI service to accelerate game asset creation, reduce development costs, and boost monetization. This tool integrates with popular game engines like Unity and Godot and enables players to create in-game content using AI.
  • UnGPT.ai (May 2025): The company developed this proprietary tool to "humanize" AI-generated text. It aims to bypass AI detection and produce more natural-sounding content while preserving the original meaning.
  • Art-Gen.AI (August 2025): This AI platform creates professional-grade images and videos. It leverages advanced models from Google and Stability AI, enhanced with Gaxos's own technology for cinematic visuals and hyper-realistic images from text prompts.
  • Bible Pray AI (December 2025): GAXOS.AI entered the digital faith and wellness market with this personalized, AI-powered platform. It offers tools for spiritual growth, scripture application, and faith-deepening.
• Gaxos Health (Preventative Wellness): This initiative launched its first AI-powered health optimization product in Q3 2024. It focuses on personalized wellness strategies by integrating AI insights with individual health data, emphasizing preventative medicine. The company aims to capture a share of the growing digital health market.
• RNK Health (Strategic Partnership): In September 2024, GAXOS.AI formed RNK Health LLC, a subsidiary in which it holds a 70% ownership stake, in partnership with Nekwellness. RNK Health provides access to health-related products, medications, supplements, and wellness services, expanding GAXOS.AI's presence in the health sector.
• Gaxos Gaming (AI-Enhanced Entertainment): Launched in 2023, this platform uses AI to personalize gaming experiences and facilitate the creation of unique in-game NFTs (Non-Fungible Tokens) by both gamers and developers. By December 31, 2025, Gaxos Gaming had launched five AI-powered titles: Space Striker AI, Brawl Bots, BattleFleet AI, Jigsaw Puzzle AI, and Gaxos AI Puzzle.

2. Financial Performance and Management's Discussion

GAXOS.AI INC. is in an early stage of commercialization, heavily investing in research and development. Management's Discussion and Analysis (MD&A) highlights the company's financial condition and results of operations for fiscal year 2025 as follows:

• Revenue: The company reported revenue of $1.5 million for the fiscal year ended December 31, 2025, a significant increase from $0.3 million in 2024. This growth primarily stems from initial sales of its newly launched AI applications and gaming platforms, showing early market acceptance of its products.
• Net Loss: GAXOS.AI incurred a net loss of $8.2 million in 2025, compared to a net loss of $5.5 million in 2024. This increased loss reflects substantial investments in product development, marketing, and operational infrastructure needed to scale its new business and expand its product portfolio.
• Operating Expenses:
  • Research & Development (R&D): R&D expenses totaled $4.0 million in 2025, up from $2.5 million in 2024. This increase underscores the company's commitment to innovation and developing new AI technologies and platforms.
  • Selling, General & Administrative (SG&A): SG&A expenses reached $4.5 million in 2025, compared to $3.0 million in 2024. Increased marketing efforts to promote new products and expand market reach, along with higher administrative overhead from growing operations, drove this rise.
• Cash Position: As of December 31, 2025, GAXOS.AI held $3.5 million in cash and cash equivalents, down from $10.0 million at the end of 2024. The company used approximately $6.5 million in cash for operating activities during 2025, primarily funding its R&D and SG&A expenditures.
• Accumulated Deficit: The accumulated deficit stood at $18.7 million as of December 31, 2025. This indicates the company has not yet achieved sustained profitability since its inception and remains in a growth phase requiring significant investment.

The company anticipates continued losses in the near term as it focuses on market penetration and scaling operations. Its ability to sustain operations will depend on generating sufficient revenue or securing additional financing.

3. Financial Health

GAXOS.AI's financial health reflects its early-stage growth and substantial investment needs.

• Cash and Liquidity: As noted, the company held $3.5 million in cash and cash equivalents as of December 31, 2025, a decrease from the prior year. The significant cash used for operating activities ($6.5 million in 2025) indicates a high reliance on existing capital and the need for future funding. The $18.7 million accumulated deficit further emphasizes the company's pre-profitability stage. Management explicitly states that sustaining operations depends on generating sufficient revenue or securing additional financing, highlighting a key liquidity risk.
• Debt: The company's financial structure appears primarily equity-funded, with operational expenses leading to a reduction in cash reserves.

4. Competitive Position

GAXOS.AI operates in highly competitive and rapidly evolving markets across AI, gaming, health, and defense. The company faces competition from:

• Established Technology Giants: Large companies like Google, Microsoft, and Amazon, which possess significant resources, existing customer bases, and extensive R&D capabilities, are also heavily investing in AI.
• Numerous AI Startups: A multitude of specialized AI companies, some of which may focus on niche areas with advanced technology or specific market advantages.
• Traditional Industry Players: Companies in the health, gaming, and defense sectors that are integrating AI into their existing offerings or developing their own AI solutions.

GAXOS.AI's competitive strategy appears to center on rapid product development, diversification across high-growth sectors, and leveraging proprietary AI technology (e.g., UnGPT.ai) to differentiate its offerings. Its ability to innovate quickly, attract and retain users, and scale its platforms will be crucial for establishing and maintaining a competitive advantage.

5. Risk Factors

Investing in GAXOS.AI INC. involves several significant risks that potential investors should carefully consider:

• Limited Operating History and Profitability: The company has a short operational history, has only recently begun generating revenue, and has a history of significant losses. There is no guarantee it will achieve or sustain profitability.
• Reliance on Key Personnel: GAXOS.AI's success heavily depends on its executive management, skilled employees, and technical advisors. Losing key individuals or an inability to attract qualified staff could severely impede its growth and operations.
• Unproven Technology Adoption: Many of its products rely on nascent and evolving AI technologies. These technologies may not gain widespread market acceptance or prove as effective or scalable as anticipated.
• User Acquisition and Retention Challenges: The company's business model requires attracting and retaining a large user base across its various platforms. Failure to effectively acquire and engage users could materially harm its financial performance.
• Data Security and Privacy Concerns: Handling large volumes of data, including sensitive health information through Gaxos Health, exposes the company to significant risks. These include data breaches, system failures, and compliance with stringent regulations like HIPAA. Such incidents could lead to substantial financial penalties, reputational damage, and loss of user trust.
• Intellectual Property Protection: Protecting its proprietary AI technology, software, and intellectual property (IP) is crucial. An inability to secure or enforce its IP rights could allow competitors to replicate its offerings, eroding its competitive advantage.
• Regulatory Landscape: The AI and technology sectors face rapidly evolving regulations concerning data privacy, ethical AI use, and intellectual property. Non-compliance or adverse regulatory changes could negatively impact the company's operations and financial condition.
• Stock Market Volatility and Liquidity: As an emerging growth company, GAXOS.AI's stock price may experience significant volatility. The company does not anticipate paying dividends in the foreseeable future, and a risk of delisting from Nasdaq exists if it fails to meet listing requirements.

6. Future Outlook

GAXOS.AI's future growth strategy focuses on continuous innovation, market expansion, and user acquisition. Key elements include:

• Aggressive R&D: The company plans to maintain high investment in R&D to develop cutting-edge AI technologies and expand its product portfolio.
• Market Diversification: GAXOS.AI will continue identifying and entering new high-growth markets where AI can provide a competitive advantage, as evidenced by its moves into defense (America First Defense.AI LLC investment) and digital wellness.
• User Engagement & Monetization: The company aims to attract and retain users across its platforms, exploring various monetization models such as subscriptions, in-app purchases, and licensing.
• Strategic Partnerships: GAXOS.AI leverages partnerships, like the one with Nekwellness for RNK Health, to accelerate market entry and expand product offerings without solely relying on organic development.
• Talent Acquisition: The company invests in attracting and retaining top AI talent to drive innovation and product excellence.

Strategic Investments (Early 2026): In March 2026, after the fiscal year end, GAXOS.AI made a significant strategic investment. It acquired a 19.99% stake in America First Defense.AI LLC for $2.9 million. This move signals the company's intent to expand into the defense AI sector, a market with substantial growth potential and strategic importance. This investment aligns with GAXOS.AI's broader strategy of diversifying its AI applications across high-value industries.

The company operates in highly competitive markets, facing established technology giants and numerous AI startups. Its ability to differentiate its offerings, scale user adoption, and achieve profitability will be critical to its long-term success. The company anticipates continued losses in the near term as it prioritizes growth and market penetration.

This summary provides a clear and informative overview of GAXOS.AI INC.'s 2025 performance and strategic direction, highlighting both its potential and inherent risks. Investors are encouraged to review the full 10-K filing for complete details.